{
    "2018-06-12": [
        [
            {
                "time": "",
                "original_text": "年初“押错题”现迎加强版 国内四价流感疫苗生产首获批",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "生产获批",
                        "加强版"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "CFDA 动真格了！大批中药注射剂说明书要改",
                "features": {
                    "keywords": [
                        "CFDA",
                        "中药注射剂",
                        "说明书修改"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药行业周报：谈龙头的持续上涨与二线品种的机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "龙头上涨",
                        "二线品种机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "研发一年豪掷近50亿 国内药企三巨头产品究竟有多牛？",
                "features": {
                    "keywords": [
                        "研发",
                        "药企三巨头",
                        "投入50亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-06-11",
                "original_text": "【医药-复星医药(600196)】江琦、张天翼：阿法骨化醇通过一致性评价，利妥昔单抗新适应症启动III期临床",
                "features": {
                    "keywords": [
                        "复星医药",
                        "阿法骨化醇",
                        "一致性评价",
                        "利妥昔单抗",
                        "III期临床"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "重庆药友制药阿法骨化醇片通过一致性评价",
                "features": {
                    "keywords": [
                        "重庆药友制药",
                        "阿法骨化醇片",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "四部门组织建设专项 支持创新药研发和产业化(受益股)",
                "features": {
                    "keywords": [
                        "四部门",
                        "创新药",
                        "研发产业化",
                        "支持政策"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}